Impact of the initial levels of laboratory variables on survival in chronic dialysis patients

American Journal of Kidney Diseases

Volumn 28, Issue 4, 1996, Pages 541-548

  Iseki, Kunitoshi ^a   Uehara, Hajime ^b   Nishime, Keizo ^b   Tokuyama, Kiyoyuki ^b   Yoshihara, Kunio ^b   Kinjo, Kazushi ^b   Shiohira, Yoshiki ^b   Fukiyama, Koshiro ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NONE

Author keywords

Dialysis patient; laboratory tests; serum albumin; survival

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; FEMALE; HEMATOCRIT; HUMAN; HYPERKALEMIA; HYPOALBUMINEMIA; HYPONATREMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; SURVIVAL; UREA NITROGEN BLOOD LEVEL;

EID: 0029795147     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90465-5     Document Type: Article

References (32)

1. Port FK: Morbidity and mortality in dialysis patients. Nephrology forum. Kidney Int 46:1728-1737, 1994
2. Iseki K, Kawazoe N, Osawa A, Fukiyama K: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43:404-409, 1993
3. Iseki K, Nishime K, Uehara H, Osawa A, Fukiyama K: Effect of renal diseases and comorbid conditions on survival in chronic dialysis patients. Nephron 68:80-86, 1994
4. Collins AC, Hanson G, Umen A, Kjellstrand C, Keshaviah P: Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 15:422-432, 1990
5. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
6. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31:103-110, 1982
7. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24:S199-S203, 1983
8. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
9. Foley RN, Parfrey PS, Hefferton D, Singh I, Simms A, Barrett BJ: Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 23:836-845, 1994
10. Lowrie EG, Lew NL, Huang WH: Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int 42:S22-S31, 1992
11. Matson M, Kjellstrand CM: Long-term follow-ups of 369 diabetic patients undergoing dialysis. Arch Intern Med 148:600-604, 1988
12. Hull AR, Parker TF III: Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, TX, September 15 to 17, 1989. Am J Kidney Dis 15:375-385, 1990
13. Cox DR: Regression models and life table. J R Stat Soc B 34:187-220, 1972
14. Harrell F: The PHGLM procedures, in Reinhards PS (ed): SAS Supplemental Library User's Guide. Cary, NC, SAS Institute, 1980, pp 119-132
15. Bergstrom J, Mamoun H, Anderstam B, Sodersten P: Middle molecules (MM) isolated from uremic ultrafiltrate (UF) and normal urine induce dose-dependent inhibition of appetite in the rat. J Am Soc Nephrol 5:488, 1994 (abstr)
16. DeFronzo RA: Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 17:118-134, 1980
17. Allon M, Takeshian A, Shanklin N: Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int 43:212-217, 1993
18. Allon M: Editorial review. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 43:1197-1209, 1993
19. Wolcott DL, Maida CA, Diamond R, Nissenson AR: Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol 6:329-338, 1986
20. Delmez JA, Slatopolsky E: Hyperphosphatemia: Its consequences and treatment in patients with chronic renal failure. Am J Kidney Dis 19:303-317, 1992
21. Kopple JD, Berg R, Houser H, Steinman TI, Teshan P: Nutritional status of patients with different levels of chronic renal insufficiency. Kidney Int 36:S184-S194, 1989
22. DeFronzo RA, Goldberg M, Agus ZS: Normal diluting capacity in hyponatremic patients: Reset osmostat or a variant of the syndrome of inappropriate antidiuretic hormone secretion. Ann Intern Med 84:538-542, 1976
23. Bell NH, Schedl HP, Bartter FC, Powell E, Smith G: An explanation for abnormal water retention and hypoosmolality in congestive heart failure. Am J Med 36:351-360, 1964
24. Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK: Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302:1373-1379, 1980
25. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
26. Foley RN, Parfrey PS: Risk factors for cardiac morbidity and mortality in dialysis patients. Curr Opin Nephrol Hypertens 3:608-614, 1994
27. Oksa H, Pasternack A, Pasanen M: Serum urea-creatinine ratio as a prognostic index in hemodialysis patients. Clin Nephrol 27:125-130, 1987
28. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y, Nakamura S, Baba S, Matsuoka H, Omae T: Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis 25:405-412, 1995
29. Vokonos PS, Kannel WB, Cupples LA: Epidemiology and risk of hypertension in the elderly: The Framingham Study. J Hypertens 6:S3-S9, 1988 (suppl 1)
30. Tell GS, Rutan GH, Kronmal RA, Bild DE, Polak JF, Wong ND, Borhami NO, Cardiovascular Health Study (CHS) Collaborative Research Group: Correlates of blood pressure in community-dwelling older adults, the Cardiovascular Health Study. Hypertension 23:59-67, 1994
31. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44:1086-1090, 1993
32. Bergstrom J, Alverstrand A, Bucht H, Gutierrez A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 25:1-6, 1986